The radioprotector ortho-phospho- L -tyrosine (pTyr) attenuates the side effects of fractionated irradiation in retinoblastoma mouse models but also decreases the local tumour control

2017 ◽  
Vol 124 (3) ◽  
pp. 462-467
Author(s):  
Alexander V. Tschulakow ◽  
Klaus Dittmann ◽  
Stephan M. Huber ◽  
Dominik Klumpp ◽  
Benjamin Stegen ◽  
...  
2013 ◽  
Vol 108 (3) ◽  
pp. 422-428 ◽  
Author(s):  
Mechthild Krause ◽  
Berit Kummer ◽  
Andre Deparade ◽  
Wolfgang Eicheler ◽  
Dorothee Pfitzmann ◽  
...  

2010 ◽  
Vol 96 (1) ◽  
pp. 116-122 ◽  
Author(s):  
Ala Yaromina ◽  
Howard Thames ◽  
Xuanjing Zhou ◽  
Sandra Hering ◽  
Wolfgang Eicheler ◽  
...  

2012 ◽  
Vol 102 (3) ◽  
pp. 444-449 ◽  
Author(s):  
Kristin Gurtner ◽  
Franziska Hessel ◽  
Wolfgang Eicheler ◽  
Annegret Dörfler ◽  
Daniel Zips ◽  
...  

2010 ◽  
Vol 49 (S 01) ◽  
pp. S11-S15
Author(s):  
C. Schütze ◽  
M. Krause ◽  
A. Yaromina ◽  
D. Zips ◽  
M. Baumann

SummaryRadiobiological and cell biological knowledge is increasingly used to further improve local tumour control or to reduce normal tissue damage after radiotherapy. Important research areas are evolving which need to be addressed jointly by nuclear medicine and radiation oncology. For this differences of the biological distribution of diagnostic and therapeutic nuclides compared with the more homogenous dose-distribution of external beam radiotherapy have to be taken into consideration. Examples for interdisciplinary biology-based cancer research in radiation oncology and nuclear medicine include bioimaging of radiobiological parameters characterizing radioresistance, bioimage-guided adaptive radiotherapy, and the combination of radiotherapy with molecular targeted drugs.


2021 ◽  
Vol 161 ◽  
pp. S1642
Author(s):  
M. Horsman ◽  
S. Nielsen ◽  
M. Sitarz ◽  
M. Høyer ◽  
B. Sørensen

Sign in / Sign up

Export Citation Format

Share Document